(Date:8/29/2008)...or International Pediatric AIDS Initiative Will ...th HIV/AIDS, WASHINGTON, Aug. 29 /PRNewswire-Firs...rom the U.S. government, Baylor College of Medicin...oday at a U.S. President,s,Emergency Plan for AIDS...nt,effort to improve care and treatment for childr...
(Date:8/29/2008)... Radiothon will benefit the Children,s Hospital ...NARDINO, Calif., Aug. 29 /PRNewswire/ -- On Tuesda...r Bros. Charities, the newly,established philanthr...h,Annual Stater Bros. Charities Kola Cares for Kid...vided 628 KOLA Bears to bring comfort to patients ...
(Date:8/29/2008)...ewswire/ -- Attorneys representing consumers in a,...rigging the price of,virtually every prescription ... are now preparing for a trial set for December 1 .../www.newscom.com/cgi-bin/prnh/20080317/AQM144LOGO ...6 on behalf of,third-party payers and consumers, c...
(Date:8/29/2008)...PRNewswire-USNewswire/ -- The U.S. Department of,L...o allow the public to,see exactly what goes into a...eral Register http://edocket.access.gpo.gov/2008/...est and latest available evidence and,scientific d...health,standards regulating occupational exposure ...
Breaking Medicine News(10 mins):Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 2Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 3Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 4Health News:Stater Bros. Charities Kola Cares for Kids Radiothon Raises $161,300 for Loma Linda University Children's Hospital 2Health News:Hagens Berman Sobol Shapiro: Attorneys Representing Consumers Prepare for $12 Billion RICO Trial Against McKesson for Alleged Drug Price Manipulation 2Health News:Hagens Berman Sobol Shapiro: Attorneys Representing Consumers Prepare for $12 Billion RICO Trial Against McKesson for Alleged Drug Price Manipulation 3Health News:Notice of Proposed Rulemaking on U.S. Department of Labor's Risk Assessment Procedures Published in Federal Register 2...gal substances have become nearly twice as prevale... high school and 28% of middle school students adm...ols. // Teens who attend schools where drugs are w...ikely to experiment with marijuana and twice as li...
...archers had linked the generation of baby boomers ... obesity and increased incidence of obesity-relate...efore. // The study was done by the researchers at..., and published in the September issue of the Amer...
...cal tourism focuses on treatment of acute illness,... among others. From October this year , the Govern... a medical tourism destination. // Senior Governme...ng medical facilities to a global audience have al...
...axy, Pharmaceutical Company has opened up its thir...in Gurgaon which was inaugurated by President A.P....ntre will focus on new drug // discovery research ...try, analytical development, pharmacology, molecul...
Other Medicine News:Health News:Promoting Medical Tourism In India 2(Date:8/27/2008)...Research Team Makes Crucial Breakthrough in Battle...n,s Disease, CHICAGO, Aug. 27 /- The...nounced that scientists at The University of Notti...le to slow or prevent the onset,of a very common t...earchers have genetically produced the first ever ...
(Date:8/26/2008)...y to present data from landmark SYNTAX clinical tr.../ -- Boston Scientific,Corporation (NYSE: BSX ) t...,events and press announcements at the European So... August 30 to September 3 in Munich, Germany., Th... SYNTAX trial,which compares percutaneous coronar...
(Date:8/26/2008)...ss., Aug. 26 /- Cambridge Research &,...of the Maestro(TM) EX In,Vivo Imaging System. The ...X technology and becomes the entry-level instrumen...hoto: http://www.newscom.com/cgi-bin/prnh/2008082...icant advancement of CRi,s unique,solid-state tuna...
(Date:8/25/2008)... to New Prevention and Treatment Strategies--, PH...entists have,discovered gene mutations that are th...hood cancer neuroblastoma. In addition, the resear...cant role in high-risk forms of,non-inherited neur..."This discovery enables us to offer the first gene...
Breaking Medicine Technology:The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 4CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 3Gene That Causes Childhood Cancer Neuroblastoma Is Found 4 2417 Million Tobacco Free Florida Campaign Ignites Statewide 14546 1 2417 Million Tobacco Free Florida Campaign Ignites Statewide 14546 2 2417 Million Tobacco Free Florida Campaign Ignites Statewide 14546 3Intercim Launches Pertinence Suite Powered by Velocity 14544 1Intercim Launches Pertinence Suite Powered by Velocity 14544 2Intercim Launches Pertinence Suite Powered by Velocity 14544 3Intercim Launches Pertinence Suite Powered by Velocity 14544 4Birner Dental Management Services Inc Announces 10 0 25 Adjusted EBITDA Increase for 2007 Versus 2006 14542 1Birner Dental Management Services Inc Announces 10 0 25 Adjusted EBITDA Increase for 2007 Versus 2006 14542 2Birner Dental Management Services Inc Announces 10 0 25 Adjusted EBITDA Increase for 2007 Versus 2006 14542 3Birner Dental Management Services Inc Announces 10 0 25 Adjusted EBITDA Increase for 2007 Versus 2006 14542 4Birner Dental Management Services Inc Announces 10 0 25 Adjusted EBITDA Increase for 2007 Versus 2006 14542 5Birner Dental Management Services Inc Announces 10 0 25 Adjusted EBITDA Increase for 2007 Versus 2006 14542 6Birner Dental Management Services Inc Announces 10 0 25 Adjusted EBITDA Increase for 2007 Versus 2006 14542 7Birner Dental Management Services Inc Announces 10 0 25 Adjusted EBITDA Increase for 2007 Versus 2006 14542 8TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia 4043 1TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia 4043 2TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia 4043 3TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia 4043 4...comolar, Potency and Slow Dissociation from HCV,Pr...stCall via COMTEX News,Network/ -- InterMune, Inc....ta on the company,s Hepatitis C virus (HCV) NS3/4A... session of the,Digestive Disease Week (DDW) meeti...ported study (DDW abstract #M1816) examined,ITMN-1...
...upport Use of Provenge as Front-line Treatment in,...lif., May 20, 2007 /PRNewswire-FirstCall/,-- Dendr...f data,from an analysis of Phase 3 Studies (D9901 ...it for patients who were initially,treated with Pr...docetaxel chemotherapy after disease progression. ...
Other Medicine Technology:InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 2InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 3InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 4InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 5Dendreon Announces Presentation of Data at American Urological,Association Annual Meeting 2Dendreon Announces Presentation of Data at American Urological,Association Annual Meeting 3Dendreon Announces Presentation of Data at American Urological,Association Annual Meeting 4Accu-Temp Cauteries provide a broad selection of tip styles for cauterization in a wide variety of ophthalmic procedures. Each single use cautery is packaged sterile, complete with a safety cap to lo
Accu-Temp® Cauteries provide a broad selection of tip styles for cauterization in a wide variety of ophthalmic procedures. Each single use cautery is packaged sterile, complete with a safety cap
Accu-Temp® Cauteries provide a broad selection of tip styles for cauterization in a wide variety of ophthalmic procedures. Each single use cautery is packaged sterile, complete with a safety cap
...inary LASIK Light Probes provide the surgeon with ...rneal interface to be easily visualized through th...ct and light scatter technique, the surgeon can en...l deposits, flap edge folds, corneal flap striae a...
Medicine Products: